NAPPA partners with Guangdong Medical Valley (MEDV)

NAPPA has formed a strategic partnership with Guangdong Medical Valley (MEDV), an ecosystem platform for biopharmaceutical full-lifecycle management and one of China’s leading biomedical industry hubs.

The partnership is structured to build a bi-directional bridge between Boston innovation and China’s industrial transformation — connecting early-stage U.S. innovators with Chinese manufacturing and clinical-development scale, while giving MEDV-resident companies a Boston-based platform for U.S. partnerships and capital.

Initial workstreams

• Joint pipeline reviews for assets suitable for cross-border out-licensing.
• Shared CRO/CDMO referrals for NAPPA member companies.
• Coordinated investor introductions across both ecosystems.